Asia Pacific Breast Implants Market Outlook and Strategic Insights by 2027

The Asia Pacific breast implants market is expected to reach US$ US$ 445.65 million in 2027 from US$ 287.32 million in 2019. The market is estimated to grow with a CAGR of 5.8% from 2020-2027.

The growth of the market is driven by the factors such as, increasing breast cancer incidence rates in Asia Pacific and rise in breast augmentation procedures in Asian countries are expected to augment the growth of the market. However, risks associated with breast implants like breast pain, infection and others is likely to have negative impact on the growth of the Asia Pacific Breast Implants market in the coming years.

Breast cancer is major health concern in the Asia Pacific region. As per the Cancer Australia organization estimated that, there will be 19,807 new female breast cancer cases in the year 2020.  It also reported that estimated 2,997 number of female deaths due to breast cancer in 2020 in Australia region. It is the second most common cancer diagnosed in Australia. Similarly, china is witnessing a huge increase in breast cancer rate. As per the Globocan 2018 report, there were 367,900 new breast cancer cases in china. Additionally, breast cancer is the leading cancer in Indian women. As per the Globocan 2018 report, there were 162,468 new cases of breast cancer and 87090 breast cancer deaths in India. Thus the growing prevalence of breast cancer in Asia Pacific region is likely to increase the demand for breast implants in the region. 

The increase in breast cancer cases is due to factors such as heredity, certain lifestyle choices, obesity and overweight, and increase in alcohol consumption.

Thus, growing prevalence of breast cancer and growing risk factors in Asia Pacific will demand breast implants.

Furthermore, Asia Pacific countries are expecting to witness huge challenge due to growing COVID-19. Due to outbreak of disease, healthcare industries has been affected badly, considering the economic conditions in current situation. Due to growing coronavirus cases, many seminars and international conference has been postponed. For instance, 9th Asia Pacific Breast Cancer Summit has been postponed after 13th to 15th march due to current growing coronavirus. After the first case in December in Wuhan, China, the COVID-19 virus, has spread to at least 180 countries and regions. In china the reported total cases of coronavirus is 84,302; in Japan it is 12,429; India is having 23,077 count. Restrictive measures have been taken to control the spread of this pandemic, however, in this measure patients undergoing for cancer, cardiology, gynecological and cosmetological treatment are not being treated on priority. Apart from overall health system, cancer care delivery system has been facing challenges due to coronavirus outbreak.

Rest of Asia Pacific Breast Implants Market Revenue and Forecast to 2027 (US$ Mn)

Asia Pacific Breast Implants – Market Segmentation

By Product

• Silicone
• Saline

By Application

• Reconstructive Surgery
• Cosmetic Surgery

By Surface Type

• Smooth
• Textured

By Country

• China
• India
• Japan
• South Korea
• Australia

Company Profiles

• Mentor Worldwide Llc
• POLYTECH Health & Aesthetics Gmbh
• Groupe Sebbin Sas
• Guangzhou Wanhe Plastic Materials Co., Ltd.
• Allergan Plc

Asia Pacific Breast Implants Report Scope